<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of pasteur-03109413</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-02T17:38:49+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Identification of a Compensatory Mutant (lpg2−REV) of Leishmania major Able To Survive as Amastigotes within Macrophages without LPG2-Dependent Glycoconjugates and Its Significance to Virulence and Immunization Strategies</title>
            <author role="aut">
              <persName>
                <forename type="first">Gerald F</forename>
                <surname>Späth</surname>
              </persName>
              <email type="md5">21c92db676a61ae8ce9372c3eef9565b</email>
              <email type="domain">pasteur.fr</email>
              <idno type="idhal" notation="string">gspaeth</idno>
              <idno type="idhal" notation="numeric">9227</idno>
              <idno type="halauthorid" notation="string">10532-9227</idno>
              <idno type="IDREF">https://www.idref.fr/148385001</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-0256-2029</idno>
              <affiliation ref="#struct-508210"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Lon-Fye</forename>
                <surname>Lye</surname>
              </persName>
              <idno type="halauthorid">306495-0</idno>
              <affiliation ref="#struct-508210"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Hiroaki</forename>
                <surname>Segawa</surname>
              </persName>
              <idno type="halauthorid">2130924-0</idno>
              <affiliation ref="#struct-127973"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Salvatore</forename>
                <surname>Turco</surname>
              </persName>
              <idno type="halauthorid">2130580-0</idno>
              <affiliation ref="#struct-127973"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Stephen</forename>
                <surname>Beverley</surname>
              </persName>
              <idno type="halauthorid">1475911-0</idno>
              <affiliation ref="#struct-508210"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Christel</forename>
                <surname>Ricard Andraos</surname>
              </persName>
              <email type="md5">4b65694f10634bc4a087f97880f1e8ff</email>
              <email type="domain">pasteur.fr</email>
            </editor>
            <funder>This work was supported by NIH grant AI31078 (to S.J.T. and S.M.B.), by the Deutscher Akademischer Austauschdienst (DAAD), and by the Human Frontiers Science Program (G.F.S.).</funder>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2021-01-13 17:21:43</date>
              <date type="whenModified">2026-04-05 14:18:05</date>
              <date type="whenReleased">2021-01-19 18:02:53</date>
              <date type="whenProduced">2004-06</date>
              <ref type="externalLink" target="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC415719"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="481486">
                <persName>
                  <forename>Christel</forename>
                  <surname>Ricard Andraos</surname>
                </persName>
                <email type="md5">4b65694f10634bc4a087f97880f1e8ff</email>
                <email type="domain">pasteur.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">pasteur-03109413</idno>
            <idno type="halUri">https://pasteur.hal.science/pasteur-03109413</idno>
            <idno type="halBibtex">spath:pasteur-03109413</idno>
            <idno type="halRefHtml">&lt;i&gt;Infection and Immunity&lt;/i&gt;, 2004, 72 (6), pp.3622-3627. &lt;a target="_blank" href="https://dx.doi.org/10.1128/IAI.72.6.3622-3627.2004"&gt;&amp;#x27E8;10.1128/IAI.72.6.3622-3627.2004&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Infection and Immunity, 2004, 72 (6), pp.3622-3627. &amp;#x27E8;10.1128/IAI.72.6.3622-3627.2004&amp;#x27E9;</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt/>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Identification of a Compensatory Mutant (lpg2−REV) of Leishmania major Able To Survive as Amastigotes within Macrophages without LPG2-Dependent Glycoconjugates and Its Significance to Virulence and Immunization Strategies</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Gerald F</forename>
                    <surname>Späth</surname>
                  </persName>
                  <email type="md5">21c92db676a61ae8ce9372c3eef9565b</email>
                  <email type="domain">pasteur.fr</email>
                  <idno type="idhal" notation="string">gspaeth</idno>
                  <idno type="idhal" notation="numeric">9227</idno>
                  <idno type="halauthorid" notation="string">10532-9227</idno>
                  <idno type="IDREF">https://www.idref.fr/148385001</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-0256-2029</idno>
                  <affiliation ref="#struct-508210"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Lon-Fye</forename>
                    <surname>Lye</surname>
                  </persName>
                  <idno type="halauthorid">306495-0</idno>
                  <affiliation ref="#struct-508210"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Hiroaki</forename>
                    <surname>Segawa</surname>
                  </persName>
                  <idno type="halauthorid">2130924-0</idno>
                  <affiliation ref="#struct-127973"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Salvatore</forename>
                    <surname>Turco</surname>
                  </persName>
                  <idno type="halauthorid">2130580-0</idno>
                  <affiliation ref="#struct-127973"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Stephen</forename>
                    <surname>Beverley</surname>
                  </persName>
                  <idno type="halauthorid">1475911-0</idno>
                  <affiliation ref="#struct-508210"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">14165</idno>
                <idno type="issn">0019-9567</idno>
                <idno type="eissn">1098-5522</idno>
                <title level="j">Infection and Immunity</title>
                <imprint>
                  <publisher>American Society for Microbiology</publisher>
                  <biblScope unit="volume">72</biblScope>
                  <biblScope unit="issue">6</biblScope>
                  <biblScope unit="pp">3622-3627</biblScope>
                  <date type="datePub">2004-06</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1128/IAI.72.6.3622-3627.2004</idno>
              <idno type="pubmed">15155672</idno>
              <idno type="pubmedcentral">PMC415719</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="mesh">Animals</classCode>
              <classCode scheme="mesh">Female</classCode>
              <classCode scheme="mesh">Mice</classCode>
              <classCode scheme="mesh">Mice, Inbred BALB C</classCode>
              <classCode scheme="mesh">Protozoan Proteins</classCode>
              <classCode scheme="mesh">Protozoan Vaccines</classCode>
              <classCode scheme="mesh">Virulence</classCode>
              <classCode scheme="mesh">Glycoconjugates</classCode>
              <classCode scheme="mesh">Glycosphingolipids</classCode>
              <classCode scheme="mesh">Humans</classCode>
              <classCode scheme="mesh">Immunization</classCode>
              <classCode scheme="mesh">Leishmania major</classCode>
              <classCode scheme="mesh">Leishmaniasis, Cutaneous</classCode>
              <classCode scheme="mesh">Macrophages, Peritoneal</classCode>
              <classCode scheme="mesh">Membrane Proteins</classCode>
              <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
              <classCode scheme="halDomain" n="sdv.mp">Life Sciences [q-bio]/Microbiology and Parasitology</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Different Leishmania species rely to different extents on abundant glycoconjugates, such as lipophosphoglycan (LPG) and related molecules, in mammalian infections. Previously, we showed that Leishmania major deletion mutants lacking the Golgi GDP-mannose transporter LPG2, which is required for assembly of the dominant phosphoglycan (PG) repeats of LPG, were unable to survive in macrophages. These lpg2- mutants, however, retained the ability to generate asymptomatic, persistent infections in mice. In contrast, Ilg and colleagues showed that Leishmania mexicana LPG2 mutants retained virulence for mice. Here we identified a partial revertant population of the L. major lpg2- mutants (designated lpg2(-)REV) that had regained the ability to replicate in macrophages and induce disease pathology through a compensatory change. Like the lpg2 parent, the lpg2(-)REV revertant was unable to synthesize LPG2-dependent PGs in the promastigote stage and thus remained highly attenuated in the ability to induce infection. However, after considerable delay lpg2(-)REV revertant-infected mice exhibited lesions, and amastigotes isolated from these lesions were able to replicate within macrophages despite the fact that they were unable to synthesize PGs. Thus, in some respects, the lpg2(-)REV amastigotes resemble L. mexicana amastigotes. Future studies of the gene(s) responsible may shed light on the mechanisms employed by L. major to survive in the absence of LPG2-dependent glycoconjugates and may also improve the potential of the lpg2- L. major line to serve as a live parasite vaccine by overcoming its tendency to revert toward virulence.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="institution" xml:id="struct-508210" status="VALID">
          <idno type="ROR">https://ror.org/01yc7t268</idno>
          <orgName>Washington University in Saint Louis</orgName>
          <orgName type="acronym">WUSTL</orgName>
          <desc>
            <address>
              <addrLine>1 Brookings Dr, St. Louis, MO 63130</addrLine>
              <country key="US"/>
            </address>
            <ref type="url">https://wustl.edu/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-127973" status="VALID">
          <idno type="IdRef">02914843X</idno>
          <idno type="ISNI">0000000121851478</idno>
          <idno type="ROR">https://ror.org/02k3smh20</idno>
          <orgName>University of Kentucky</orgName>
          <orgName type="acronym">UK</orgName>
          <date type="start">1865-01-01</date>
          <desc>
            <address>
              <addrLine>Lexington, KY 40506-0046, USA</addrLine>
              <country key="US"/>
            </address>
            <ref type="url">http://www.uky.edu/</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>